Business Context and Reporting Period
Company: Innovative Industrial Properties, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 21, 2017 (Event Date)
Reporting Period: Single event disclosure regarding a material definitive agreement.
The Company, through its operating partnership subsidiary, entered into a definitive purchase and sale agreement to acquire a property in Arizona in a sale-leaseback transaction. The property consists of approximately 358,000 square feet of greenhouse and industrial space, to be leased to a subsidiary of The Pharm, LLC, a state-licensed medical-use cannabis operator.
Key Financial Metrics and Transaction Terms
| Metric | Value |
|---|---|
| Purchase Price | $15.0 million |
| Tenant Improvement (TI) Allowance | Up to $3.0 million |
| Total Investment | $18.0 million (Purchase Price + TI Allowance) |
| Initial Annualized Base Rent | $2,520,000 |
| Implied Yield | 14% (of Purchase Price + TI Allowance) |
| Annual Rent Escalation | 3.25% |
| Lease Term | 15 years initial, plus two 5-year extension options |
| Security Deposit | $630,000 |
| Property Management Fee | 1.5% of Base Rent |
Funding Source: The Company intends to fund the transaction using remaining proceeds from its December 2016 IPO and proceeds from its October 2017 offering of 9.0% Series A Cumulative Redeemable Preferred Stock.
Material Changes and Transaction Structure
- Acquisition Type: Sale-leaseback transaction with a triple-net lease structure.
- Tenant Obligations: The tenant (The Pharm subsidiary) is responsible for all structural repairs, maintenance, insurance, and taxes.
- Guaranty: Any entity affiliated with The Pharm operating in the Arizona cannabis industry must provide a full guaranty of the lease obligations.
- Rent Abatement:
- $5.0 million of the Purchase Price ($58,333.33/month) is abated until March 31, 2018.
- Base Rent attributable to the TI Allowance ($35,000/month) is abated until the earlier of the TI drawdown or three months after lease commencement.
Outlook, Risks, and Contingencies
Management Commentary: The Company expects to enter into the lease concurrently with the closing of the acquisition. The transaction is subject to ongoing diligence and satisfaction of closing conditions.
Risks and Contingencies:
- Closing Uncertainty: There is no assurance the acquisition will be consummated on the described terms or at all.
- Forward-Looking Statements: The report contains forward-looking statements regarding the acquisition and lease, which are subject to risks and uncertainties that could cause actual results to differ materially.
- Regulatory Context: The tenant operates in the medical-use cannabis industry, which carries inherent regulatory risks not explicitly detailed in this specific filing but implied by the tenant's business nature.
Investor Verification Checklist
- Verify the final closing of the transaction and the actual date of lease commencement.
- Confirm the utilization of the $3.0 million TI Allowance and the corresponding rent abatement period.
- Review the full text of the Purchase Agreement (Exhibit 10.1) for specific representations, warranties, and closing conditions.
- Monitor the tenant's operational status and compliance with Arizona state cannabis regulations.
- Assess the impact of the 14% yield and 3.25% escalations on the Company's future cash flow projections.